Phase II Randomized Trial Evaluating the Administration of Sorafenib or Pravastatin or Association Sorafenib-pravastatin or Best Supportive Care for the Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis.
Phase of Trial: Phase II
Latest Information Update: 04 May 2017
At a glance
- Drugs Pravastatin (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms PRODIGE 21
- 28 Apr 2017 Status changed from active, no longer recruiting to completed.
- 22 Jun 2016 Planned primary completion date changed from 1 Aug 2015 to 1 Nov 2016.
- 22 Jun 2016 Planned End Date changed from 1 Feb 2016 to 1 May 2017.